ReviewInfection and drug resistance2026
Antimicrobial Resistance in Somalia: A Growing Public Health Crisis in a Fragile Health System-A Narrative Review of Challenges, Healthcare Gaps, and Policy Recommendations.
Review in Infection and drug resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Antimicrobial resistance (AMR) has emerged as one of the most serious global public health threats and represents a growing concern in fragile and conflict-affected countries such as Somalia. The increasing emergence of resistant bacterial pathogens threatens the effectiveness of commonly used antimicrobial therapies and contributes to increased morbidity, mortality, healthcare costs, and prolonged hospital stays. In Somalia, prolonged conflict, weak healthcare infrastructure, population displacement, limited diagnostic capacity, and widespread inappropriate antibiotic use have accelerated the development and spread of antimicrobial resistance. Unregulated over-the-counter access to antibiotics, self-medication practices, inadequate infection prevention and control (IPC) measures, and poor antimicrobial stewardship further compound the problem. Methods: This narrative review synthesizes evidence from peer-reviewed literature, international reports, and programmatic documents to examine the burden of antimicrobial resistance, key healthcare challenges, current response strategies, and policy priorities in Somalia. Literature searches were conducted using PubMed, Google Scholar, Scopus, and grey literature sources including reports from the World Health Organization (WHO), United Nations agencies, and humanitarian organizations. Publications published between 2010 and 2026 were considered. Results: The findings demonstrate that antimicrobial resistance in Somalia is driven by multiple interconnected factors, including irrational antibiotic prescribing, limited microbiological diagnostic services, weak surveillance systems, healthcare-associated infections, inadequate regulation of pharmaceutical distribution, and persistent humanitarian crises. Current interventions remain fragmented and under-resourced despite increasing global recognition of antimicrobial resistance as a major health security threat. Conclusion: Strengthening antimicrobial stewardship, improving laboratory and surveillance capacity, expanding infection prevention and control measures, regulating antibiotic sales, and supporting healthcare worker education are critical for reducing the growing burden of resistant infections in Somalia. Sustainable investment in healthcare infrastructure and coordinated national policy implementation will be essential to improving patient safety and protecting the effectiveness of antimicrobial therapies in fragile healthcare settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.